Evome Medical Technologies Inc. (LNDZF)
OTCMKTS
· Delayed Price · Currency is USD
0.0040
-0.0410 (-91.11%)
At close: Apr 22, 2025
LNDZF Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Feb '22 Feb 28, 2022 | Feb '21 Feb 28, 2021 | Feb '20 Feb 29, 2020 | 2015 - 2019 |
| Interest and Dividend Income | - | - | - | - | - | 0.31 | Upgrade
|
| Total Interest Expense | 2.98 | 2.64 | 0.71 | 0.39 | - | - | Upgrade
|
| Net Interest Income | -2.98 | -2.64 | -0.71 | -0.39 | - | 0.31 | Upgrade
|
| Commissions and Fees | - | - | - | - | - | 0.08 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | - | -0.18 | -0.06 | Upgrade
|
| Other Revenue | 48.34 | 62.63 | 40.31 | 18.31 | 0.15 | 0.02 | Upgrade
|
| Revenue Before Loan Losses | 45.36 | 59.99 | 39.61 | 17.92 | -0.03 | 0.35 | Upgrade
|
| Provision for Loan Losses | - | - | - | - | - | 0.02 | Upgrade
|
| Revenue | 45.36 | 59.99 | 39.61 | 17.92 | -0.03 | 0.33 | Upgrade
|
| Revenue Growth (YoY) | -19.17% | 51.46% | 120.96% | - | - | -72.13% | Upgrade
|
| Salaries & Employee Benefits | - | - | - | - | 0.24 | - | Upgrade
|
| Cost of Services Provided | 49.95 | 63.64 | 41.33 | 18.08 | 0.75 | 1.62 | Upgrade
|
| Total Operating Expenses | 53.84 | 68.15 | 43.5 | 18.92 | 0.99 | 1.65 | Upgrade
|
| Operating Income | -8.48 | -8.16 | -3.89 | -1 | -1.02 | -1.31 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | 0 | -0.23 | 0.02 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -8.8 | -6.71 | -7.38 | -4.82 | -2.67 | -1.31 | Upgrade
|
| Impairment of Goodwill | -10.95 | -10.23 | - | -5.52 | - | - | Upgrade
|
| Other Unusual Items | 0.07 | 4.75 | -15.27 | 5.87 | - | - | Upgrade
|
| Pretax Income | -23.51 | -15.55 | -22.84 | -4.47 | -2.67 | -1.35 | Upgrade
|
| Income Tax Expense | 0.02 | 0.06 | -3.76 | -0.1 | - | - | Upgrade
|
| Earnings From Continuing Ops. | -23.53 | -15.6 | -19.08 | -4.37 | -2.67 | -1.35 | Upgrade
|
| Earnings From Discontinued Ops. | - | - | - | - | - | -0.57 | Upgrade
|
| Net Income | -23.53 | -15.6 | -19.08 | -4.37 | -2.67 | -1.92 | Upgrade
|
| Net Income to Common | -23.53 | -15.6 | -19.08 | -4.37 | -2.67 | -1.92 | Upgrade
|
| Shares Outstanding (Basic) | 88 | 73 | 55 | 44 | 34 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 88 | 73 | 55 | 44 | 34 | 34 | Upgrade
|
| Shares Change (YoY) | 28.35% | 33.97% | 25.70% | 29.09% | 0.03% | - | Upgrade
|
| EPS (Basic) | -0.27 | -0.21 | -0.35 | -0.10 | -0.08 | -0.06 | Upgrade
|
| EPS (Diluted) | -0.27 | -0.21 | -0.35 | -0.10 | -0.08 | -0.06 | Upgrade
|
| Free Cash Flow | 5.37 | -1.12 | -1.76 | -3.76 | -0.98 | -0.2 | Upgrade
|
| Free Cash Flow Per Share | 0.06 | -0.01 | -0.03 | -0.09 | -0.03 | -0.01 | Upgrade
|
| Operating Margin | -18.68% | -13.61% | -9.82% | -5.56% | - | -392.09% | Upgrade
|
| Profit Margin | -51.88% | -26.01% | -48.16% | -24.39% | - | -575.46% | Upgrade
|
| Free Cash Flow Margin | 11.83% | -1.87% | -4.45% | -20.97% | - | -59.10% | Upgrade
|
| Revenue as Reported | - | - | - | - | -0.03 | 0.35 | Upgrade
|
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Financial Services template. Financial Sources.